CompaniesMicroConstants

MicroConstants

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

102

By Phase

PHASE2: 2

By Status

TERMINATED: 1COMPLETED: 1

Recent Trials

NCT03449524Collaborator
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
PHASE2Terminated
69 participants
Started: Aug 1, 2018 · Completed: Aug 5, 2020
NCT03422510Collaborator
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
PHASE2Completed
33 participants
Started: Apr 15, 2018 · Completed: Jul 31, 2020
Related Companies
Bioagilytix
acquired